|
AU742293B2
(en)
|
1997-06-12 |
2001-12-20 |
Aventis Pharma Limited |
Imidazolyl-cyclic acetals
|
|
WO2014144952A2
(en)
|
2013-03-15 |
2014-09-18 |
Peter Walter |
Modulators of the eif2alpha pathway
|
|
TW201808903A
(zh)
|
2016-05-05 |
2018-03-16 |
嘉來克生命科學有限責任公司 |
整合應激途徑之調節劑
|
|
TW201808888A
(zh)
|
2016-05-05 |
2018-03-16 |
嘉來克生命科學有限責任公司 |
整合應激途徑之調節劑
|
|
TWI920577B
(zh)
|
2016-05-05 |
2026-04-01 |
美商嘉來克生命科學有限責任公司 |
整合應激途徑之調節劑
|
|
TW201808914A
(zh)
|
2016-05-05 |
2018-03-16 |
嘉來克生命科學有限責任公司 |
整合應激途徑之調節劑
|
|
CA3026983A1
(en)
|
2016-06-08 |
2017-12-14 |
Glaxosmithkline Intellectual Property Development Limited |
Chemical compounds
|
|
RU2018145734A
(ru)
|
2016-06-08 |
2020-07-14 |
Глэксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед |
Химические соединения в качестве ингибиторов atf4 пути
|
|
CN110730777A
(zh)
|
2017-06-07 |
2020-01-24 |
葛兰素史密斯克莱知识产权发展有限公司 |
作为atf4通路抑制剂的化学化合物
|
|
EP3649108A1
(en)
|
2017-07-03 |
2020-05-13 |
GlaxoSmithKline Intellectual Property Development Limited |
2-(4-chlorophenoxy)-n-((1 -(2-(4-chlorophenoxy)ethynazetidin-3-yl)methyl)acetamide derivatives and related compounds as atf4 inhibitors for treating cancer and other diseases
|
|
WO2019008506A1
(en)
|
2017-07-03 |
2019-01-10 |
Glaxosmithkline Intellectual Property Development Limited |
N- (3- (2- (4-CHLOROPHENOXY) ACETAMIDO) BICYCLO [1.1.1] PENTAN-1-YL) -2-CYCLOBUTANE-1-CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS ATF4 INHIBITORS FOR THE TREATMENT OF CANCER AND OTHER DISEASES
|
|
IL301709B2
(en)
|
2017-08-09 |
2025-07-01 |
Denali Therapeutics Inc |
Compounds, compositions and methods
|
|
TW201920129A
(zh)
*
|
2017-09-01 |
2019-06-01 |
美商戴納立製藥公司 |
化合物、組合物及方法
|
|
MX2020004538A
(es)
|
2017-11-02 |
2020-09-18 |
Calico Life Sciences Llc |
Moduladores de la vía de estrés integrada.
|
|
JP2021501785A
(ja)
|
2017-11-02 |
2021-01-21 |
カリコ ライフ サイエンシーズ エルエルシー |
統合的ストレス経路の調節剤
|
|
UY37957A
(es)
|
2017-11-02 |
2019-05-31 |
Abbvie Inc |
Moduladores de la vía de estrés integrada
|
|
BR112020008825A2
(pt)
|
2017-11-02 |
2020-10-20 |
Calico Life Sciences Llc |
moduladores da via de estresse integrada
|
|
SG11202004009TA
(en)
|
2017-11-02 |
2020-05-28 |
Calico Life Sciences Llc |
Modulators of the integrated stress pathway
|
|
MX2020004537A
(es)
|
2017-11-02 |
2020-10-05 |
Calico Life Sciences Llc |
Moduladores de la vía integrada del estrés.
|
|
UY37958A
(es)
|
2017-11-02 |
2019-05-31 |
Abbvie Inc |
Moduladores de la vía de estrés integrada
|
|
UY37956A
(es)
|
2017-11-02 |
2019-05-31 |
Abbvie Inc |
Moduladores de la vía de estrés integrada
|
|
EP3704125B1
(en)
|
2017-11-02 |
2026-03-11 |
Calico Life Sciences LLC |
Modulators of the integrated stress pathway
|
|
JP2021508336A
(ja)
|
2017-12-13 |
2021-03-04 |
プラクシス バイオテック エルエルシー |
統合的ストレス応答経路の阻害剤
|
|
WO2019183589A1
(en)
|
2018-03-23 |
2019-09-26 |
Denali Therapeutics Inc. |
Modulators of eukaryotic initiation factor 2
|
|
WO2019193540A1
(en)
|
2018-04-06 |
2019-10-10 |
Glaxosmithkline Intellectual Property Development Limited |
Heteroaryl derivatives of formula (i) as atf4 inhibitors
|
|
WO2019193541A1
(en)
|
2018-04-06 |
2019-10-10 |
Glaxosmithkline Intellectual Property Development Limited |
Bicyclic aromatic ring derivatives of formula (i) as atf4 inhibitors
|
|
US11166942B2
(en)
|
2018-06-05 |
2021-11-09 |
Praxis Biotech LLC |
Inhibitors of integrated stress response pathway
|
|
JP2021529814A
(ja)
|
2018-07-09 |
2021-11-04 |
グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited |
化学化合物
|
|
WO2020031107A1
(en)
|
2018-08-08 |
2020-02-13 |
Glaxosmithkline Intellectual Property Development Limited |
Chemical compounds
|
|
TW202545902A
(zh)
|
2018-10-11 |
2025-12-01 |
美商嘉來克生命科學有限責任公司 |
整合應激路徑之前藥調節劑
|
|
CR20210426A
(es)
|
2019-02-13 |
2021-09-30 |
Denali Therapeutics Inc |
Compuestos, composiciones y métodos
|
|
EP3924341A4
(en)
|
2019-02-13 |
2022-11-02 |
Denali Therapeutics Inc. |
Compounds, compositions and methods
|
|
SG11202107871UA
(en)
|
2019-02-25 |
2021-08-30 |
Praxis Biotech LLC |
Inhibitors of integrated stress response pathway
|
|
US20220177456A1
(en)
|
2019-03-06 |
2022-06-09 |
Denali Therapeutics Inc. |
Compounds, compositions and methods
|
|
MX2021012904A
(es)
|
2019-04-23 |
2022-01-18 |
Evotec Int Gmbh |
Moduladores de la via de respuesta al estres integrada.
|
|
WO2020216766A1
(en)
|
2019-04-23 |
2020-10-29 |
Evotec International Gmbh |
Modulators of the integrated stress response pathway
|
|
PH12021552759A1
(en)
|
2019-04-30 |
2022-07-04 |
Abbvie Inc |
Substituted cycloalkyls as modulators of the integrated stress pathway
|
|
AR118836A1
(es)
|
2019-04-30 |
2021-11-03 |
Calico Life Sciences Llc |
Moduladores de la vía de tensión integrada
|
|
JP2022536901A
(ja)
|
2019-06-12 |
2022-08-22 |
プラクシス バイオテック エルエルシー |
統合的ストレス応答経路の阻害剤
|
|
JP2022536663A
(ja)
|
2019-06-12 |
2022-08-18 |
プラクシス バイオテック エルエルシー |
統合的ストレス応答経路のモジュレーター
|
|
CA3162526A1
(en)
|
2020-01-28 |
2021-08-05 |
Christopher John Brown |
Modulators of the integrated stress response pathway
|
|
ES2997335T3
(en)
|
2020-10-22 |
2025-02-17 |
Evotec Int Gmbh |
Modulators of the integrated stress response pathway
|
|
MX2023004677A
(es)
|
2020-10-22 |
2023-05-24 |
Evotec Int Gmbh |
Moduladores de la via de respuesta integrada al estres.
|
|
CA3195290A1
(en)
|
2020-10-22 |
2022-04-28 |
Holly Victoria Atton |
Modulators of the integrated stress response pathway
|